Literature DB >> 10440331

Co-trimoxazole in HIV-1 infection.

M Badri, G Maartens, R Wood, R Ehrlich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10440331     DOI： 10.1016/S0140-6736(05)75237-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Implementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIV.

Authors:  Anand A Date; Marco Vitoria; Reuben Granich; Mazuwa Banda; Mayada Youssef Fox; Charlie Gilks
Journal:  Bull World Health Organ       Date:  2009-10-23       Impact factor: 9.408

2.  National policy development for cotrimoxazole prophylaxis in Malawi, Uganda and Zambia: the relationship between Context, Evidence and Links.

Authors:  Eleanor Hutchinson; Justin Parkhurst; Sam Phiri; Di M Gibb; Nathaniel Chishinga; Benson Droti; Susan Hoskins
Journal:  Health Res Policy Syst       Date:  2011-06-16

3.  Assessment of isoniazid preventive therapy in the reduction of tuberculosis among ART patients in Arba Minch Hospital, Ethiopia.

Authors:  Ashenafi Abossie; Tsegaye Yohanes
Journal:  Ther Clin Risk Manag       Date:  2017-03-24       Impact factor: 2.423

Review 4.  Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review.

Authors:  Christine Manyando; Eric M Njunju; Umberto D'Alessandro; Jean-Pierre Van Geertruyden
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.